16-fluoro-5-androsten-17-one has been researched along with 3-methylquercetin in 1 studies
Studies (16-fluoro-5-androsten-17-one) | Trials (16-fluoro-5-androsten-17-one) | Recent Studies (post-2010) (16-fluoro-5-androsten-17-one) | Studies (3-methylquercetin) | Trials (3-methylquercetin) | Recent Studies (post-2010) (3-methylquercetin) |
---|---|---|---|---|---|
11 | 0 | 1 | 464 | 16 | 269 |
Protein | Taxonomy | 16-fluoro-5-androsten-17-one (IC50) | 3-methylquercetin (IC50) |
---|---|---|---|
Cytochrome P450 1A1 | Homo sapiens (human) | 0.056 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 1.261 | |
Xanthine dehydrogenase/oxidase | Homo sapiens (human) | 2.51 | |
Mitogen-activated protein kinase 10 | Homo sapiens (human) | 6.3 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 6.3 | |
Cytochrome P450 1B1 | Homo sapiens (human) | 0.017 | |
Inositol polyphosphate multikinase | Homo sapiens (human) | 2.2 | |
Enoyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 5 | |
3-oxoacyl-acyl-carrier protein reductase | Plasmodium falciparum (malaria parasite P. falciparum) | 8.3 | |
Aurora kinase B | Homo sapiens (human) | 4.34 | |
Inositol hexakisphosphate kinase 2 | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbhuiya, TK; Jayaprakash, V; Mohd Siddique, MU; Sinha, BN | 1 |
1 review(s) available for 16-fluoro-5-androsten-17-one and 3-methylquercetin
Article | Year |
---|---|
Phytoestrogens and their synthetic analogues as substrate mimic inhibitors of CYP1B1.
Topics: Animals; Antineoplastic Agents, Phytogenic; Classification; Cluster Analysis; Cytochrome P-450 CYP1B1; Enzyme Inhibitors; Humans; Molecular Mimicry; Neoplasms; Phytoestrogens | 2019 |